Effect of Topical Anesthesia on Hemodynamics During the Induction Period in Patients Undergo Cardiac Surgery.
Effect of Topical Anesthesia Combined With Intravenous Induction on Hemodynamics During the Induction Period in Patients Undergo Cardiac Surgery: a Randomized Controlled Study
1 other identifier
interventional
96
1 country
1
Brief Summary
The aim of the induction is to decrease stress response of endotracheal intubation. It is also important to keep hemodynamics stable during and after the induction period. Previous studies have shown that topical anesthesia can provide excellent superior supraglottic and subglottic local anesthetic effects and can significantly reduce the dosage of intravenous anesthetics. Therefore, it is significant to explore whether the combination of topical anesthesia and intravenous anesthetics could decrease the stress response of endotracheal intubation and keep hemodynamics stable during and after the induction period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Mar 2021
Shorter than P25 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 9, 2021
CompletedStudy Start
First participant enrolled
March 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2022
CompletedJune 2, 2022
May 1, 2022
2 months
January 24, 2021
May 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The area under the curve of baseline blood pressure
The area under the curve (AUC) of blood pressure below baseline from the beginning of general anesthesia induction to the surgery beginning.
From the beginning of general anesthesia induction(T1) to the surgery beginning(T2). T1 is when induction drug (midazolam) is administered. T2 is defined as the time of the skin incision. It will take up to 1hour or 2hours.
Secondary Outcomes (10)
The frequency and types of vasoactive drugs used.
From the beginning of general anesthesia induction(T1) to the surgery beginning(T2). T1 is when induction drug (midazolam) is administered. T2 is defined as the time of the skin incision. It will take up to 1hour or 2hours.
The incidence of arrhythmias.
From the beginning of general anesthesia induction(T1) to the surgery beginning(T2). T1 is when induction drug (midazolam) is administered. T2 is defined as the time of the skin incision. It will take up to 1hour or 2hours.
cardiac systolic function:Left Ventricular Ejection Fraction (LVEF)
Preoperative, intraoperative
cardiac diastolic function:E/E' (the ratio of E peak and E') or E/A :(the ratio of E peak and A peak)
Preoperative, intraoperative
cardiac output monitoring indicator: CO(cardiac output)
Intraoperative
- +5 more secondary outcomes
Study Arms (2)
The combined topical anesthesia induction group
EXPERIMENTALThe superior glottic mucosa would be anesthetized 3 times with a vaporizer before intravenous anesthesia. After the intravenous induction, a catheter would be inserted to provide the subglottic anesthesia,3-5ml 2% lidocaine would be used for supraglottic anesthesia, and 3ml 1% tetracaine would be used for subglottic anesthesia.
The routine induction group
NO INTERVENTIONThe superior glottic mucosa would be anesthetized 3 times with a vaporizer before intravenous anesthesia. After the intravenous induction, a catheter would be inserted to provide the subglottic anesthesia.In the routine induction group,all procedures will be the same as those of the topical anesthesia group, The drug will be replaced with constant volume saline.
Interventions
The superior glottic mucosa would be anesthetized 3 times with a vaporizer before intravenous anesthesia. After the intravenous induction, a catheter would be inserted to provide the subglottic anesthesia,3-5ml 2% lidocaine would be used for supraglottic anesthesia, and 3ml 1% tetracaine would be used for subglottic anesthesia.
Eligibility Criteria
You may qualify if:
- Patients scheduled to accept elective /major cardiac surgery;
- Patients older than 18 years and younger than 85 years;
- Patients of The American Society of Anesthesiologists ( ASA )Ⅱ - Ⅳ level grade;
- Patients signed the informed consent form for the clinical study;
You may not qualify if:
- Patients cannot cooperate to topical anesthesia;
- Patients with a left cardiac assist device prior to surgery;
- Patients with aortic dissection;
- Patients with Intra Aortic Balloon Pump (IABP) prior to surgery;
- Patients treated with Extracorporeal Membrane Oxygenation (ECMO) prior to surgery;
- Patients with difficult airway;
- Patients with high sensitivity and hypersensitivity to lidocaine and tetracaine;
- Patients with atrioventricular block;
- Hemoglobin(Hb)\<80g/L;
- Patients who have participated in other clinical studies during the last 3 months;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meng-Lv
Jinan, Shandong, 250000, China
Related Publications (1)
Chen TT, Lv M, Wang JH, Wei CS, Gu CP, Wang YL. Addition of topical airway anaesthesia to conventional induction techniques to reduce haemodynamic instability during the induction period in patients undergoing cardiac surgery: protocol for a randomised controlled study. BMJ Open. 2022 Jan 25;12(1):e053337. doi: 10.1136/bmjopen-2021-053337.
PMID: 35078841DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meng Lv, doctor
Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 24, 2021
First Posted
February 9, 2021
Study Start
March 5, 2021
Primary Completion
April 27, 2021
Study Completion
April 27, 2022
Last Updated
June 2, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share